Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.
2.

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators.

Diabetologia. 2011 Jun;54(6):1308-17. doi: 10.1007/s00125-011-2084-x. Epub 2011 Feb 26.

PMID:
21359582
4.

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators.

JAMA. 2005 Jan 26;293(4):437-46.

PMID:
15671428
5.

Glucose control in acute myocardial infarction: a pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care.

Sampaio CR, Franco DR, Goldberg DJ, Baptista J, Eliaschewitz FG.

Diabetes Technol Ther. 2012 Feb;14(2):117-24. doi: 10.1089/dia.2011.0157. Epub 2011 Dec 19.

PMID:
22181063
7.

Glucose-insulin-potassium for suspected acute myocardial infarction.

Chaudhuri A, Nesto R, Dandona P.

JAMA. 2012 Sep 5;308(9):859; author reply 859-60. doi: 10.1001/jama.2012.9768. No abstract available.

PMID:
22948688
8.

Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials.

Zhao YT, Weng CL, Chen ML, Li KB, Ge YG, Lin XM, Zhao WS, Chen J, Zhang L, Yin JX, Yang XC.

Heart. 2010 Oct;96(20):1622-6. doi: 10.1136/hrt.2010.194563. Review.

PMID:
20937749
9.
10.
11.

A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Mamas MA, Neyses L, Fath-Ordoubadi F.

Exp Clin Cardiol. 2010 Summer;15(2):e20-4.

14.

Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).

van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Gans RO, de Boer MJ, Zijlstra F; GIPS Investigators.

Am Heart J. 2005 Apr;149(4):585-91.

PMID:
15990738
15.

High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.

Zhang L, Zhang L, Li YH, Zhang HY, Chen ML, Gao MM, Hu AH, Yang HS, Yang HS.

Eur J Clin Invest. 2005 Mar;35(3):164-70.

PMID:
15733070
17.

The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia.

Lazzeri C, Valente S, Chiostri M, Attanà P, Picariello C, Gensini GF.

Acta Diabetol. 2013 Jun;50(3):293-300. doi: 10.1007/s00592-011-0325-6. Epub 2011 Oct 9.

PMID:
21984048
18.

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

van der Horst IC, Zijlstra F, van 't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ; Zwolle Infarct Study Group.

J Am Coll Cardiol. 2003 Sep 3;42(5):784-91.

19.

[Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].

Yang YM, Zhu J, Tan HQ, Liang Y, Zhang Y, Li Y, Li JD, Liu LS; National Coordinator Office of CREATE in China.

Zhonghua Yi Xue Za Zhi. 2008 Jul 8;88(26):1806-10. Chinese.

PMID:
19040013
20.

Glucose-insulin-potassium solution for acute myocardial infarction.

Janiger JL, Cheng JW.

Ann Pharmacother. 2002 Jun;36(6):1080-4. Review.

PMID:
12022912

Supplemental Content

Support Center